Twynsta

Twynsta Indications/Uses

telmisartan + amlodipine

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Treatment of essential hypertension in adults.
Replacement Therapy: Patients receiving telmisartan and amlodipine from separate tablets may instead receive TWYNSTA containing the same component doses.
Add on therapy: TWYNSTA is indicated in patients whose blood pressure is not adequately controlled on telmisartan or amlodipine monotherapy.
Initial therapy: TWYNSTA may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
Base the choice of Twynsta tablets as initial therapy for hypertension on an assessment of potential benefits and risks including whether the patient is likely to tolerate the starting dose of Twynsta tablets.
Patients with moderate or severe hypertension are at relatively high risk for cardiovascular events (such as stroke, heart attacks and heart failure), kidney failure and vision problems, so prompt treatment is clinically relevant. Consider the patient's baseline blood pressure, the target goals and the incremental likelihood of achieving goals with a combination compared to monotherapy when deciding whether to use Twynsta tablets as initial therapy. Individual blood pressure goals may vary based upon the patient's risk.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in